Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

794 trials

Showing 20 of 794 results

Large-scale testing (Phase 3)UnknownNCT00141947
What this trial is testing

Bexarotene Treatment in Schizophrenia

Who this might be right for
Schizophrenia
Beersheva Mental Health Center 15
Large-scale testing (Phase 3)Ended earlyNCT01908192
What this trial is testing

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Who this might be right for
Schizophrenia
SyneuRx International (Taiwan) Corp 60
Post-approval studies (Phase 4)UnknownNCT02282085
What this trial is testing

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

Who this might be right for
Schizophrenia
Matt Byerly 200
Not applicableStudy completedNCT01394601
What this trial is testing

Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 600
Large-scale testing (Phase 3)Study completedNCT00086593
What this trial is testing

Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

Who this might be right for
Schizophrenia
GlaxoSmithKline 209
Not applicableUnknownNCT04335916
What this trial is testing

Survey on Pre-ECT Evaluation and ECT Application

Who this might be right for
DepressionCatatoniaSchizophrenia+3 more
Klinički Bolnički Centar Zagreb 30
Post-approval studies (Phase 4)WithdrawnNCT02286206
What this trial is testing

Study of the Effect of Dosing on Clozapine Levels

Who this might be right for
Psychotic DisordersSchizophrenia
University of British Columbia
Not applicableStudy completedNCT04668248
What this trial is testing

Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing

Who this might be right for
Medication Administered in ErrorAntipsychotics and Neuroleptics Toxicity
Brigham and Women's Hospital 47
Testing effectiveness (Phase 2)Study completedNCT00733668
What this trial is testing

Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca
Not applicableUnknownNCT00686946
What this trial is testing

The National Register of Antipsychotic Medication in Pregnancy (NRAMP)

Who this might be right for
PregnancyMental Disorders
The Alfred 500
Not applicableLooking for participantsNCT05748990
What this trial is testing

Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

Who this might be right for
SchizophreniaHealthy
Centre for Addiction and Mental Health 20
Not applicableActive Not RecruitingNCT07351240
What this trial is testing

The Acupuncture Treatment Effect in Patients With Schizophrenia

Who this might be right for
Mental Health
Calo Psychiatric Center 100
Post-approval studies (Phase 4)Study completedNCT00331825
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Who this might be right for
SchizophreniaExtrapyramidal Syndrome
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 70
Testing effectiveness (Phase 2)WithdrawnNCT04761861
What this trial is testing

Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

Who this might be right for
SchizophreniaDyslipidemias
Sadat City University
Large-scale testing (Phase 3)Study completedNCT01235559
What this trial is testing

RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 604
Post-approval studies (Phase 4)Study completedNCT00292370
What this trial is testing

Quetiapine Augmentation for Treatment-resistant PTSD

Who this might be right for
Combat DisordersStress Disorders, Post-Traumatic
VA Office of Research and Development 124
Post-approval studies (Phase 4)Study completedNCT01724359
What this trial is testing

Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag, S.A. 95
Testing effectiveness (Phase 2)Study completedNCT04461119
What this trial is testing

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

Who this might be right for
Schizophrenia
Newron Pharmaceuticals SPA 138
Post-approval studies (Phase 4)Not Yet RecruitingNCT06546475
What this trial is testing

A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

Who this might be right for
Psychosis
National Taiwan University Hospital 20
Post-approval studies (Phase 4)Study completedNCT00433121
What this trial is testing

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

Who this might be right for
Dementia
Sykehuset Innlandet HF 24
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation